公司原药产品立项评估数据

根据行业专家、一线医生和销售人员的推荐，采集全球范围内医药行业的产品市场信息、注册信息、专利技术信息以及法规信息，为企业原药新产品立项提供多维度情报信息支撑；同时借助大数据分析技术，对相关产品进行全面评估评分，挖掘高价值的目标产品，为原药产品立项提供精准的线索，提升产品立项工作的效能。第一，数据处理：从各类商业和官方数据库提取产品市场规模、增长趋势、竞争对手、生产技术难度、欧美高端市场需求、专利门槛、法规管制门槛等提取多个特征值，并根据多个特征值生成该产品的多个技术指标； 第二，数据算法：采用机器学习技术中的决策树算法对产品进行评分分级，高分产品作为立项优选。打分列通过如下方式计分：市场规模大于等于10亿得2分，5亿~10亿之间得1分，小于5亿不得分。增长率大于等于15%得1分，小于15%不得分。竞争对手小于等于5家得1分，高于5家不得分。合成技术难度低得0.5分，中或高不得分。需要欧美药政注册得0.5分，无需注册的不得分。专利过期得0.5分，未过期不得分。非管制产品得0.5分，管制产品不得分。总分5分，高分产品作为立项优选。

Based on recommendations from industry experts, frontline clinicians and sales personnel, this dataset collects global pharmaceutical industry product market information, registration data, patent technology information and regulatory information, providing multi-dimensional intelligence support for enterprises to initiate new active pharmaceutical ingredient (API) projects. Meanwhile, leveraging big data analysis technology, it conducts comprehensive evaluation and scoring of relevant products, identifies high-value target products, offers precise clues for API project initiation, and improves the efficiency of project initiation work.

1. Data Processing: Extract multiple characteristic values from various commercial and official databases, including product market scale, growth trend, competitors, production technology difficulty, demand in high-end European and American markets, patent threshold and regulatory control threshold. Generate multiple technical indicators for the products based on these characteristic values.

2. Data Algorithm: Adopt the decision tree algorithm in machine learning to score and grade the products, with high-scoring products as the preferred options for project initiation. The scoring criteria are as follows:
- 2 points if the market size is ≥ 1 billion USD, 1 point if the market size ranges from 500 million to 1 billion USD, and 0 points if the market size is less than 500 million USD;
- 1 point if the growth rate is ≥ 15%, and 0 points if the growth rate is less than 15%;
- 1 point if the number of competitors is ≤ 5, and 0 points if the number of competitors exceeds 5;
- 0.5 points if the synthetic technology difficulty is low, and 0 points if the difficulty is medium or high;
- 0.5 points if registration with European and American drug regulatory authorities is required, and 0 points if no registration is needed;
- 0.5 points if the patents have expired, and 0 points if the patents have not expired;
- 0.5 points for non-regulated products, and 0 points for regulated products.

The total score is 5 points, and high-scoring products are the preferred options for API project initiation.

搜集汇总

数据集介绍

特点

该数据集包含58条原药产品评估数据，涵盖市场规模、增长率等多维度信息，用于企业新产品立项评估，采用决策树算法进行评分分级。